End-to-End CRO Platform

The Cyagen End-to-End CRO Platform offers a comprehensive suite of advanced preclinical solutions, specializing in customized gene-edited models, humanized mice, iPSCs, and robust pharmacodynamic testing across all therapeutic modalities. By optimizing and accelerating gene therapy workflows through dedicated AAV design, manufacturing, and evaluation services, we empower global researchers to seamlessly advance breakthroughs from discovery to IND.

HomeCRO Services

Cyagen Preclinical CRO Services

Backed by a highly experienced technical team and a deep portfolio of validated disease models, Cyagen delivers robust in vivo and in vitro pharmacology services to characterize drug efficacy, PK/PD profiles, and biomarker responses. We specialize in translating complex therapeutic concepts into reliable preclinical data, offering extensive therapeutic expertise across immunology, neurology, metabolic diseases, ophthalmology, oncology, and rare diseases. Our integrated workflows are engineered to streamline rigorous safety and functional evaluation, providing global biopharmaceutical partners with the high-precision data required to confidently advance novel candidates toward clinical development.

Therapeutic Area

Our specialized scientific team brings years of peer-reviewed project experience to your specific pipeline challenges, optimizing study designs for high-impact therapeutic areas:

Innovative Drug R&D

We provide comprehensive preclinical efficacy and safety studies that have successfully accelerated pipeline development for our biopharmaceutical partners. Our testing capabilities accommodate a wide range of drug modalities:

Antibody

Accelerate therapeutic antibody discovery with fully human antibody platforms, AI-powered analysis, functional screening, and in vivo validation.

Cell Therapy

Advance CAR-T, CAR-NK, and universal cell therapy programs with integrated support from antibody discovery and CAR design to cell engineering and in vivo efficacy testing.

Gene Therapy

Streamline gene therapy development with integrated solutions covering target discovery, AAV vector design, disease model generation, and in vivo efficacy validation.

ADC/AOC

De-risk targeted conjugate therapeutics with end-to-end ADC/AOC solutions spanning fully human antibody discovery, payload delivery assessment, in vitro assays, and humanized model validation.

Oligonucleotide Therapy

Support ASO, siRNA, and precision gene modulation programs with full-cycle CRO services from in vitro knockdown screening to translational in vivo validation.

INTEGRATED PRECLINICAL CAPABILITIES

From Therapeutic Expertise to Translational Execution

Across each therapeutic area, Cyagen combines validated disease models, custom gene-edited models, and integrated in vivo pharmacology services. From model selection and study design to efficacy evaluation and data analysis, our end-to-end platform helps researchers generate reliable preclinical data and advance promising therapeutic candidates with greater confidence.

Explore our models

Request a Preclinical CRO Services Consultation

Partner with Cyagen to advance your preclinical studies. Share your project goals with us and receive customized support.

Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:

Yes, I want to receive updates on products, services, and events from Cyagen.

You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.

By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

End-to-End CRO Platform

Cyagen Preclinical CRO Services

Therapeutic Area

Neuroscience

Ophthalmology

Oncology

Metabolic

Cardiovascular